Becotatugvedotin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Becotatugvedotin, covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma [Phase 2]